CVE-2015-3956
highPriorität · verfolgen · 39OT-Risiko · erhöhtEPSS 0.010 · 61. PerzentilEUUSEPSS · bewertet 2026-10-27
Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
Behebungen
Hersteller-Fix, Mitigation oder Workaround, wie von den Quellen veröffentlicht.
Noch kein Hersteller-Fix; eine Mitigation ist verfügbar.
- MitigationPlum A+ Infusion Systemcisa_csaf_ot
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationPlum A+3 Infusion Systemcisa_csaf_ot
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
- MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closedcisa_csaf_ot
For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.
cvss
Technischer Schweregrad, 0–10. Eine Zeile je Quelle.
Basiswert 0–10 · höher = schwerwiegender · Vektor überfahren zum Auflösen⚠ Quellen uneinig · high–critical · 7.6–10
schwächen
Die CWE-Schwächeklassen, zu denen dies gehört.
betroffene Produkte (12)
Betroffene Produkte und Versionsbereiche.
- Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed: <=3.13alle Versionencisa_csaf_otUS
- Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed≤ 3.13cisa_csaf_otUS
- pifzer plum a+ infusion system firmware≤ 13.4nvdUScpe:2.3:o:pifzer:plum_a\+_infusion_system_firmware:*:*:*:*:*:*:*:*
- pifzer plum a+3 infusion system firmware≤ 13.6nvdUScpe:2.3:o:pifzer:plum_a\+3_infusion_system_firmware:*:*:*:*:*:*:*:*
- pifzer symbiq infusion system firmware≤ 3.13nvdUScpe:2.3:o:pifzer:symbiq_infusion_system_firmware:*:*:*:*:*:*:*:*
Advisories (1)
Hersteller- und Ökosystem-Meldungen dazu.
- ICSA-15-161-01Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities2015-03-13icsa · cisa_csaf_otUS
This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov
auch bekannt als (3)
Weitere Namen und Kennungen dieser Entität.
quellen
Welche Quellen diesen Datensatz belegen und wann.
Referenzen (4)
Externe Belege — Patches, Meldungen, Analysen.
Angreifer nutzen Schwachstellen wie diese gegen im Internet exponierte Dienste aus. Sehen Sie mit einem kostenlosen Passiv-Scan, was exponiert ist.
Kostenloser Scan